Enago and Future Science share a common goal – enhancing communication among clinicians, researchers and decision makers. Together they understand that for applied science and R&D research to translate into innovative solutions, it must reach the right people.

Where Future Sciences’ eBooks and journals offer a channel for exposure, Enago ensures manuscripts submitted by ESL authors in the fields of applied science are not dismissed on the basis of poor language and are given the best chance of acceptance.

Through this partnership, geographical and language barriers are broken down, and scientific advancements can lead the way.

---

About Future Science

Future Science and Newlands Press, imprints of Future Science Group, focus on applied science and intellectual property issues in R&D. Their journals and eBooks take readers through the pharmaceutical R&D pipeline – from drug discovery, delivery, pharmacokinetics and analytical techniques, through to commentary and analysis on patent and IP issues. Future Science’s flagship gold open access journal, Future Science OA, also embraces the importance of publishing all good-quality research, and covers all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are of relevance to human health.

---

About Enago

Enago is the trusted name in author services for the global research community. Since 2005, we have worked with researchers in more than 125 countries improving the communication of their research and helping them to achieve success in publication. Enago is a preferred partner for leading publishers, societies as well as universities worldwide. Our "Author First, Quality First" approach ensures that our authors receive only the best quality output and a superior user experience at all times.

Enago actively promotes all principles of ethical publishing and encourages its authors by offering resources, services and support, all of which are educational, relevant and appropriate.

---